Latest clinical outcomes update for Firesorb, Firehawk and VitaFlow - EuroPCR 2021
Cutting-edge technologies: clinical updates on TES, BRS, TAVR and LAA closure - EuroPCR 2023
PCR 2022 - Транскатетерный клапан VitaFlow TAVI (MicroPort)
Latest clinical evidence and practical aspects to start Reducer therapy in your centre - #EuroPCR
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes #PCRLV 2022
Embrace the innovation in PCI and TAVR - EuroPCR 2022
Contemporary adoption of invasive coronary physiology with microcatheter-based technology - #EuroPCR
Firehawk® Rapamycin Target Eluting Coronary Stent System Features
Firehawk™ Rapamycin Target Eluting Coronary Stent System
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
Addressing Diabetes Globally with an innovative solution - EuroPCR 2021
Vitaflow for mens health
Embrace the future of mitral and tricuspid repair and replacement - EuroPCR 2021
Firesorb
⭐ Leading with Evidence, Choosing With Confidence - (ENGLISH) #SOLACICACI2021 Symposium
The future of PCI seems bright - The MagicTouch sirolimus-coated balloon - EuroPCR 2021
EuroPCR 2021 - Focus on TAVI valve-in-valve
XLIMIT - Randomized controlled Trial to assess endothelization of Xlimus DES - EuroPCR 2021
Next Generation Structural Heart Pipeline - EuroPCR 2021
EBC main overview and the impact to clinical practice - EuroPCR 2021
